ASX-listed AVITA Medical hits 19-month high on US FDA nod

AVITA Medical

08/06/2023 01:55

** Shares of AVITA Medical  AVH.AX  rise as much as 19.8% to
A$5.14, there highest since Nov. 8, 2021
    ** Medical technology co says it got U.S. FDA premarket
approval for use of RECELL System to treat full-thickness skin
defects 
    ** Co says the system was first approved in the U.S for
treatment of severe burn in 2018 
    ** Stock posts its biggest intra-day percentage gain since
Feb 24
    ** Stock has more than doubled in value this year as of last
close 
    


 (Reporting by Navya Mittal in Bengaluru)
 ((navya.mittal@thomsonreuters.com))